{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:33Z","timestamp":1788599553609,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","award":["PRIP scheme"],"award-info":[{"award-number":["PRIP scheme"]}],"id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019125","name":"NIPER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","award":["ANRF\/IRG\/2025\/000562\/LS"],"award-info":[{"award-number":["ANRF\/IRG\/2025\/000562\/LS"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118763","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:49:12Z","timestamp":1786171752000},"page":"118763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of selective estrogen receptor modulators (SERMs) as anticancer agents for ER-positive breast cancer"],"prefix":"10.1016","volume":"142","author":[{"given":"Anurag","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mythri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripunjay","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnikula Kshatriya Parvathi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhagar","family":"Selvaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan Kumar","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118763_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13065-018-0472-8","article-title":"Estrogen alpha receptor antagonists for the treatment of breast cancer: a review","volume":"12","author":"Sharma","year":"2018","journal-title":"Chem Cent J"},{"key":"10.1016\/j.bmc.2026.118763_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2026.118763_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2026.118763_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2006.09.004","article-title":"The role of estrogen in the initiation of breast cancer","volume":"102","author":"Russo","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bmc.2026.118763_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156802606776173483","article-title":"Estrogen receptors as therapeutic targets in breast cancer","volume":"6","author":"Ariazi","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0030","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1529\/biophysj.106.099382","article-title":"Understanding ligand binding effects on the conformation of estrogen receptor \u03b1-DNA complexes: a combinational quartz crystal microbalance with dissipation and surface plasmon resonance study","volume":"92","author":"Peh","year":"2007","journal-title":"Biophys J"},{"issue":"3","key":"10.1016\/j.bmc.2026.118763_bb0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmc.2026.118763_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2002.138.re9","article-title":"Rapid actions of steroid receptors in cellular signaling pathways","volume":"2002","author":"Cato","year":"2002","journal-title":"Sci STKE"},{"key":"10.1016\/j.bmc.2026.118763_bb0045","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1210\/en.2010-1368","article-title":"GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1\/2 and estrogen receptor alpha (ER\u03b1) phosphorylation signals","volume":"152","author":"Gao","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmc.2026.118763_bb0050","doi-asserted-by":"crossref","first-page":"19399","DOI":"10.1074\/jbc.M110.195826","article-title":"Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression","volume":"286","author":"Lucki","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10059-009-0045-8","article-title":"Tectoridin, a poor ligand of estrogen receptor \u03b1, exerts its estrogenic effects via an ERK-dependent pathway","volume":"27","author":"Kang","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2026.118763_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2019.05.023","article-title":"Estrogen signaling: an emanating therapeutic target for breast cancer treatment","volume":"177","author":"Saha","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1289\/ehp.1104526","article-title":"Bisphenol a induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts","volume":"120","author":"Pupo","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bmc.2026.118763_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12672-014-0174-1","article-title":"GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast","volume":"5","author":"Scaling","year":"2014","journal-title":"Horm Cancer"},{"key":"10.1016\/j.bmc.2026.118763_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/mend.11.6.0009","article-title":"Coactivator and corepressor regulation of the agonist\/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen","volume":"11","author":"Smith","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bmc.2026.118763_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133853","article-title":"Selective estrogen receptor modulators (SERMs) for the treatment of ER+ breast cancer: an overview","volume":"1270","author":"Das","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118763_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70206","article-title":"Selective estrogen receptor modulators (SERMs): advances, challenges, and future prospects in ER+ breast cancer therapy","volume":"359","author":"Saini","year":"2026","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2026.118763_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2026.118763_bb0095","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JME-13-0173","article-title":"Understanding nuclear receptor form and function using structural biology","volume":"5","author":"Rastinejad","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bmc.2026.118763_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2016.02.026","article-title":"Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism","volume":"112","author":"Ahmed","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/dmd.116.073437","article-title":"Application of mice humanized for CYP2D6 to the study of tamoxifen metabolism and drug-drug interaction with antidepressants","volume":"45","author":"MacLeod","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2026.118763_bb0110","doi-asserted-by":"crossref","first-page":"24830","DOI":"10.1021\/acs.jmedchem.5c02894","article-title":"Fragment-to-lead medicinal chemistry publications in 2024: a tenth annual perspective","volume":"68","author":"Twigg","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0115","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/acs.jmedchem.0c02044","article-title":"Structure-enabled discovery of novel macrocyclic inhibitors targeting glutaminase 1 allosteric binding site","volume":"64","author":"Xu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bmcl.2018.12.065","article-title":"Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes","volume":"29","author":"He","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118763_bb0125","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.jmedchem.3c01093","article-title":"Discovery of novel aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung cancer","volume":"67","author":"Qin","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0140","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/jo952279l","article-title":"New highly stereoselective synthesis of (Z)-4-hydroxytamoxifen and (Z)-4-hydroxytoremifene via McMurry reaction","volume":"61","author":"Gauthier","year":"1996","journal-title":"J Org Chem"},{"issue":"24","key":"10.1016\/j.bmc.2026.118763_bb0145","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1021\/jo035164n","article-title":"Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator","volume":"68","author":"Yu","year":"2003","journal-title":"J Org Chem"},{"issue":"5063","key":"10.1016\/j.bmc.2026.118763_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/212733b0","article-title":"Preparation and identification of cis and trans isomers of a substituted triarylethylene","volume":"212","author":"Bedford","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118763_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212575","article-title":"Manipulating estrogenic\/anti-estrogenic activity of triphenylethylenes towards development of novel anti-neoplastic SERMs","volume":"22","author":"Elnakib","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118763_bb0160","doi-asserted-by":"crossref","first-page":"25903","DOI":"10.1021\/acsomega.3c01682","article-title":"Structure-activity relationships of triphenylethylene derivatives and their evaluation as anticancer and antiviral agents","volume":"8","author":"Ahmed","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118763_bb0165","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1074\/jbc.273.16.9357","article-title":"Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis","volume":"273","author":"J\u00e4nicke","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0170","first-page":"248","article-title":"Process development for the total synthesis of the novel drug metabolite carboxy toremifene as a standard reference material along with characterization and purity assessment for antidoping quality control purposes","volume":"15","author":"Kumar","year":"2023","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.bmc.2026.118763_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464358","article-title":"Purification and characterization of pure curcumin, desmethoxycurcumin, and bisdemethoxycurcumin from north-East India Lakadong turmeric (Curcuma longa)","volume":"1708","author":"Vardhini","year":"2023","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.bmc.2026.118763_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide-carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118416","article-title":"Phthalimide-benzoic acid hybrids as potent aldose reductase inhibitors: synthesis, enzymatic kinetics, and in silico characterization","volume":"131","author":"Hoti","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbi.2010.07.019","article-title":"3\u03b2-Hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica, inhibits the proliferation and migration of MDA-MB-231 cells","volume":"188","author":"Sathya","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118763_bb0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1039\/D5MO00039D","article-title":"Thioridazine induces phospholipid accumulation and necroptosis in parental and tamoxifen-resistant breast cancer cells","volume":"21","author":"Mythri","year":"2025","journal-title":"Mol Omics"},{"key":"10.1016\/j.bmc.2026.118763_bb0205","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/cbin.11853","article-title":"Tamoxifen modulates mitochondrial dynamics through AMPK and MAPK during nutrition deprivation","volume":"46","author":"Vijayakumar","year":"2022","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.bmc.2026.118763_bb0210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER\u2014a CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J Comput Chem"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2026.118763_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2026.118763_bb0220","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0230","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2013.02.008","article-title":"Considering the impact drug-like properties have on the chance of success","volume":"18","author":"Yusof","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118763_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1098-2280(2001)37:1<55::AID-EM1006>3.0.CO;2-5","article-title":"Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals","volume":"37","author":"Prival","year":"2001","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.bmc.2026.118763_bb0240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm040835a","article-title":"Derivation and validation of toxicophores for mutagenicity prediction","volume":"48","author":"Kazius","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0245","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118763_bb0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140125","article-title":"Discovery of novel thiophene[2,3-d]pyrimidine-thiazole derivative as a promising MNK inhibitor to treat breast cancer","volume":"1321","author":"Zhu","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118763_bb0260","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/D2SC06860E","article-title":"Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold","volume":"14","author":"Liu","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2026.118763_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113091","article-title":"Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion","volume":"211","author":"Qiu","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114846","article-title":"The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance","volume":"244","author":"Ye","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114860","article-title":"Discovery of novel hydroxyamidine-based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors","volume":"245","author":"Zhou","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118763_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70186","article-title":"Targeting EGFR with quinazoline-4-one\/chalcone hybrids: design, synthesis, and anticancer evaluation","volume":"359","author":"El-Gazzar","year":"2026","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2026.118763_bb0285","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1039\/D5MD01165E","article-title":"Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasis","volume":"17","author":"V","year":"2026","journal-title":"RSC Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:36:26Z","timestamp":1788597386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0968089626002191"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118763","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of selective estrogen receptor modulators (SERMs) as anticancer agents for ER-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118763"}}